Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort.
Ramonda R, Lorenzin M, Chimenti MS, Atzeni F, Semeraro A, D'Angelo S, Selmi C, Ortolan A, Marchesoni A, Manara M, Luchetti Gentiloni MM, Santo L, Salvarani C, Cauli A, Rossini M, Amato G, Cozzi G, Scagnellato L, Ferraioli M, Carriero A, Fracassi E, Giorgio F, Doria A, Foti R, Carletto A; on behalf Spondyloarthritis and Psoriatic Arthritis SIR Study Group “Antonio Spadaro”. Ramonda R, et al. Among authors: luchetti gentiloni mm. Arthritis Res Ther. 2024 Sep 28;26(1):172. doi: 10.1186/s13075-024-03401-x. Arthritis Res Ther. 2024. PMID: 39342310 Free PMC article.
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis.
Ramonda R, Lorenzin M, Chimenti MS, D'Angelo S, Marchesoni A, Selmi C, Lubrano E, Santo L, Luchetti Gentiloni MM, Atzeni F, Cauli A, Manara M, Rossini M, Foti R, Cozzi G, Scagnellato L, Ferraioli M, Carriero A, Luciano N, Ruzzon F, Fatica M, Fracassi E, Doria A, Foti R, Carletto A. Ramonda R, et al. Among authors: luchetti gentiloni mm. Front Immunol. 2024 Jul 15;15:1435599. doi: 10.3389/fimmu.2024.1435599. eCollection 2024. Front Immunol. 2024. PMID: 39076975 Free PMC article.
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients.
Luchetti Gentiloni MM, Paci V, Cimaroli I, Agostinelli A, Giannoni M, Campanati A, Diotallevi F, Carotti M, Sessa F, Sordillo R, Macchini C, Fiorini F, Massaccesi L, Ciferri M, Gigli M, Marconi V, Perini L, Marani A, Giovagnoni A, Polonara G, Offidani AM, Benfaremo D, Proft F, Poddubnyy D, Moroncini G. Luchetti Gentiloni MM, et al. Rheumatology (Oxford). 2024 Aug 1;63(8):2152-2161. doi: 10.1093/rheumatology/kead566. Rheumatology (Oxford). 2024. PMID: 37878802 Free PMC article.
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study.
Luchetti Gentiloni MM, Paci V, Carletto A, Zabotti A, Ramonda R, Chimenti MS, Dagna L, Luciano N, Piccinelli A, Giovannini I, Striani G, Boffini N, Sandri G, Possemato N, Pantano I, Benfaremo D, Salvarani C, Ciccia F, Selmi C, Moroncini G. Luchetti Gentiloni MM, et al. Arthritis Res Ther. 2023 Oct 11;25(1):196. doi: 10.1186/s13075-023-03182-9. Arthritis Res Ther. 2023. PMID: 37821952 Free PMC article.
Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trial.
Ferrarini A, Vacca A, Solimando AG, Tavio M, Acquaviva R, Rocchi M, Nitti C, Salvi A, Menditto V, Luchetti Gentiloni MM, Russo A, Moretti M, Pavani M, Giacometti A, Bonifazi M, Zuccatosta L, Romani L, Racanelli V, Moroncini G, Gabrielli A, Pomponio G. Ferrarini A, et al. Among authors: luchetti gentiloni mm. Eur J Clin Invest. 2023 Feb;53(2):e13898. doi: 10.1111/eci.13898. Epub 2022 Nov 26. Eur J Clin Invest. 2023. PMID: 36380693 Clinical Trial.